Table 1.
Potential migraine-related effects of CGRP administered by different routes in rodents
CGRP delivery | Phenotype | Species and reference |
---|---|---|
Intravenous |
|
Rat Bhatt et al. (2015) |
|
Rat Lappe et al. (1987) |
|
|
Rat Siren and Feuerstein 1988 |
|
|
Rat Cumberbatch et al. (1999) |
|
|
Rat Petersen et al. (2004) |
|
|
Rat Petersen et al. 2005a, b) |
|
|
Rat Levy et al. (2005) |
|
Intracerebroventricular |
|
Rat Bhatt et al. (2014) |
|
Mouse Kaiser et al. (2012) |
|
|
Mouse Mason et al. (2017) |
|
|
Rat Huang et al. (2000) |
|
|
Rat Pecile et al. (1987) |
|
|
Mouse Schorscher-Petcu et al. (2009) |
|
Intrathecal |
|
Mouse Mogil et al. (2005) |
|
Rat Oku et al. (1987) |
|
|
Mouse Marquez de Prado et al. (2009) |
|
Intraperitoneal |
|
Mouse Mason et al. (2017) |
|
Mouse Rea et al. (2018) |
|
|
Mouse Kaiser et al. (2017) |
|
Dural and epidural |
|
Rat Levy et al. 2005 |
|
Rat Yao et al. (2017) |
|
|
Mouse Burgos Vega et al. (2017) |
|
Subcutaneous and intradermal |
|
Rat Chu et al. (2000) |
|
Rat Nakamura-Craig and Gill (1991) |
|
|
Mouse Mogil et al. (2005) |
|
|
Mouse Marquez de Prado et al. (2009) |